Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert B Jenkins

Showing results (141-150 of 269) with videos related to

Pageof 27
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2018
Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate CancerRobert J Rounbehler, Anders E Berglund, Travis Gerke, et al.
Genes, Chromosomes & Cancer|May 31, 2022
Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual-color dual-fusion FISH studiesMarie-France Gagnon, Holly E Berg, Reid G Meyer, et al.
Journal of Neuropathology and Experimental Neurology|August 7, 2021
Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway ActivationCristiane M Ida, Derek R Johnson, Asha A Nair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trialEdith A Perez, Amylou C Dueck, Ann E McCullough, et al.
Oncotarget|April 8, 2017
Genetic landscape of extreme responders with anaplastic oligodendrogliomaMatthias Holdhoff, Gregory J Cairncross, Thomas M Kollmeyer, et al.
Molecular Cancer Therapeutics|August 31, 2019
Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain BarrierSynnøve Nymark Aasen, Heidi Espedal, Christopher Florian Holte, et al.
Neuro-Oncology Practice|November 18, 2024
Histopathologic and molecular profile of gliomas diagnosed in Lagos, NigeriaLateef A Odukoya, Cristiane M Ida, Jeanette E Eckel-Passow, et al.
American Journal of Human Genetics|April 10, 2012
Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencingAndy Itsara, Lisenka E L M Vissers, Karyn Meltz Steinberg, et al.
Breast Cancer Research and Treatment|February 20, 2013
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)Edith A Perez, Michael F Press, Amylou C Dueck, et al.
Genes, Chromosomes & Cancer|February 16, 2019
RNA sequencing identifies a novel USP9X-USP6 promoter swap gene fusion in a primary aneurysmal bone cystPatrick R Blackburn, Jaime I Davila, Rory A Jackson, et al.
Pageof 27

Showing results (141-150 of 269) with videos related to

Sort By:
Pageof 27
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 16, 2018
Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate CancerRobert J Rounbehler, Anders E Berglund, Travis Gerke, et al.
Genes, Chromosomes & Cancer|May 31, 2022
Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual-color dual-fusion FISH studiesMarie-France Gagnon, Holly E Berg, Reid G Meyer, et al.
Journal of Neuropathology and Experimental Neurology|August 7, 2021
Polymorphous Low-Grade Neuroepithelial Tumor of the Young (PLNTY): Molecular Profiling Confirms Frequent MAPK Pathway ActivationCristiane M Ida, Derek R Johnson, Asha A Nair, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trialEdith A Perez, Amylou C Dueck, Ann E McCullough, et al.
Oncotarget|April 8, 2017
Genetic landscape of extreme responders with anaplastic oligodendrogliomaMatthias Holdhoff, Gregory J Cairncross, Thomas M Kollmeyer, et al.
Molecular Cancer Therapeutics|August 31, 2019
Improved Drug Delivery to Brain Metastases by Peptide-Mediated Permeabilization of the Blood-Brain BarrierSynnøve Nymark Aasen, Heidi Espedal, Christopher Florian Holte, et al.
Neuro-Oncology Practice|November 18, 2024
Histopathologic and molecular profile of gliomas diagnosed in Lagos, NigeriaLateef A Odukoya, Cristiane M Ida, Jeanette E Eckel-Passow, et al.
American Journal of Human Genetics|April 10, 2012
Resolving the breakpoints of the 17q21.31 microdeletion syndrome with next-generation sequencingAndy Itsara, Lisenka E L M Vissers, Karyn Meltz Steinberg, et al.
Breast Cancer Research and Treatment|February 20, 2013
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)Edith A Perez, Michael F Press, Amylou C Dueck, et al.
Genes, Chromosomes & Cancer|February 16, 2019
RNA sequencing identifies a novel USP9X-USP6 promoter swap gene fusion in a primary aneurysmal bone cystPatrick R Blackburn, Jaime I Davila, Rory A Jackson, et al.
Pageof 27